<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03109119</url>
  </required_header>
  <id_info>
    <org_study_id>08/16/IEC / JMMC&amp;RI</org_study_id>
    <nct_id>NCT03109119</nct_id>
  </id_info>
  <brief_title>Does Sevoflurane Cause Genomic Damage</brief_title>
  <official_title>Does Sevoflurane Induce Genomic Instability in Patients Undergoing General Anaesthesia?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jubilee Mission Medical College and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jubilee Mission Medical College and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to find out if sevoflurane causes any cell damage to patients undergoing
      general anaesthesia. In case of any damage, the reversibility of the damage is also assessed.
      This is a prospective, comparative study carried out in all children scheduled for surgical
      repair of cleft lip or palate admitted in the Department of Plastic Surgery under Smile Train
      organisation ìn our hospital,who satisfy the inclusion and exclusion criteria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      STUDY GOALS AND OBJECTIVES

        1. To find out if sevoflurane induces genomic instability in children undergoing cleft lip
           and palate repair.

        2. To assess the magnitude of genomic damage caused by the sevoflurane anaesthesia.

        3. To evaluate the reversibility of the induced genomic instability when exposure is
           discontinued.

      STUDY DESIGN Type of study : Prospective Comparative Study Research population : All children
      scheduled for surgical repair of cleft lip or palate admitted in the Department of Plastic
      Surgery of our hospital, who satisfy the inclusion and exclusion criteria.

      Sample Size : A total of 60 children will be enrolled for the study. METHODOLOGY Children
      scheduled to undergo surgical repair of cleft lip or palate were enrolled for the study,
      after addressing the inclusion and exclusion criteria.

      A peripheral blood sample of 1.5 ml (S-1) will be taken before the induction of anaesthesia
      .All children will be randomly allocated into two groups - group S and P.All children will be
      premedicated with Inj.Glycopyrolate 0.01 mg/kg . Children in group S will be induced with
      sevoflurane, whereas children in group P will be induced with propofol.All children will be
      intubated using I / V Vecuronium 0.1 mg / kg .Analgesia will be provided using I / V Fentanyl
      1.5 mcg / kg. Depth of anaesthesia will be maintained with sevoflurane in group S and with
      propofol infusion in group P. The vitals will be monitored as usual intraop and the children
      will be extubated at the end of the surgery.

      Peripheral blood samples of 1.5 ml each will be taken immediately after extubation (S-2) ,
      after 48 hours (S-3)and after 120 hours (S-4).A fifth blood sample (S-5) will be taken on the
      14th postoperative day All the blood samples will be evaluated for genomic instability using
      Alkaline Comet Assay by the Genetics Lab of our hospital.

      STATISTICAL ANALYSIS

      The findings of this study will be analysed using Chi-square test, Student's t-test,
      Mann-Whitney U test, mean and standard deviation to yield the final results. The study will
      be considered statistically significant with a p value of less than 0.05
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2017</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>All children will be randomly allocated into two groups - group S and P. Children in group S will be anaesthetised with sevoflurane, whereas children in group P will be anaesthetised with propofol.
Peripheral blood samples of 1.5 ml each will be taken immediately after extubation (S-2) , after 48 hours (S-3)and after 120 hours (S-4).A fifth blood sample (S-5) will be taken on the 14th postoperative day.
These blood samples will be evaluated for genomic instability using Alkaline Comet Assay and micronucleus test by the Genetics Lab of our hospital.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>This is a double blinded study, where the participants are randomly selected using a computer - generated number and allocated to any one of the two groups. Both the patient and the outcome assessor will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Genomic instability</measure>
    <time_frame>It will be assessed at 2 hours after anaesthesia.</time_frame>
    <description>Genomic instability will be assessed using comet assay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genomic instability</measure>
    <time_frame>It will be assessed 48 hours after anaesthesia.</time_frame>
    <description>Genomic instability will be assessed using comet assay.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reversibility of the genomic instability</measure>
    <time_frame>It will be assessed on fifth day after anaesthesia.</time_frame>
    <description>Assessed using comet assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reversibility of genomic instability</measure>
    <time_frame>It will be assessed on the 14th day after anaesthesia.</time_frame>
    <description>It will be assessed using comet assay.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia; Adverse Effect</condition>
  <arm_group>
    <arm_group_label>Group S</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients will be induced and maintained with sevoflurane during anaesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group P</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>These patients will be induced and maintained with propofol during anaesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>The patients in the group S will be exposed to routine concentrations of sevoflurane during anaesthesia.</description>
    <arm_group_label>Group S</arm_group_label>
    <other_name>sevorane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>These patients will be induced with propofol 1.5 mg / kg and maintained with propofol infusion.</description>
    <arm_group_label>Group P</arm_group_label>
    <other_name>fresofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Children must have isolated cleft lip or palate.

          -  The surgery must be a primary repair of cleft lip or palate.

          -  The minimum duration of the surgery must be 90 minutes.

        Exclusion Criteria

          -  Children who have undergone previous surgery.

          -  Children who have syndromic cleft lip or palate.

          -  Children with bleeding disorders.

          -  Children with known allergy to any of the concerned drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vigil Peter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jubilee Mission Medical College and Research Institute, Thrissur, India</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vigil Peter, MD</last_name>
    <phone>918593821000</phone>
    <email>drpeteralapatt@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alex George, PhD</last_name>
    <phone>914872432200</phone>
    <email>alexgeorge@jmmc.ac.in</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jubilee Mission Medical College and Research Institute</name>
      <address>
        <city>Thrissur</city>
        <state>Kerala</state>
        <zip>680005</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vigil Peter, MD</last_name>
      <phone>918593821000</phone>
      <email>drpeteralapatt@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Alex George, PhD</last_name>
      <phone>914872432200</phone>
      <email>alexgeorge@jmmc.ac.in</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <results_reference>
    <citation>Szyfter K, Szulc R, Mikstacki A, Stachecki I, Rydzanicz M, Jałoszyński P. Genotoxicity of inhalation anaesthetics: DNA lesions generated by sevoflurane in vitro and in vivo. J Appl Genet. 2004;45(3):369-74.</citation>
    <PMID>15306730</PMID>
  </results_reference>
  <results_reference>
    <citation>Musak L, Smerhovsky Z, Halasova E, Osina O, Letkova L, Vodickova L, Polakova V, Buchancova J, Hemminki K, Vodicka P. Chromosomal damage among medical staff occupationally exposed to volatile anesthetics, antineoplastic drugs, and formaldehyde. Scand J Work Environ Health. 2013 Nov;39(6):618-30. doi: 10.5271/sjweh.3358. Epub 2013 Mar 22.</citation>
    <PMID>23525098</PMID>
  </results_reference>
  <results_reference>
    <citation>Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The HUman MicroNucleus Project--An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res. 1999 Jul 16;428(1-2):271-83. Review.</citation>
    <PMID>10517999</PMID>
  </results_reference>
  <results_reference>
    <citation>Wiesner G, Schiewe-Langgartner F, Lindner R, Gruber M. Increased formation of sister chromatid exchanges, but not of micronuclei, in anaesthetists exposed to low levels of sevoflurane. Anaesthesia. 2008 Aug;63(8):861-4. doi: 10.1111/j.1365-2044.2008.05498.x. Epub 2008 Jun 6.</citation>
    <PMID>18540930</PMID>
  </results_reference>
  <results_reference>
    <citation>Tania K.de Araujo, Roseane L, Flora M.B.B, Nilson C.R, Cristina W.P, Ricardo Manoel da Cruz et al-Genotoxic effects of anaesthetics in OT personnel evaluated by micronuclei tests Journal of Anaesthesia and Clinical Science ISSN 2049-9752,10.7243/2049-9752-2-26,2013</citation>
  </results_reference>
  <results_reference>
    <citation>Rozgaj R, Kasuba V, Brozović G, Jazbec A. Genotoxic effects of anaesthetics in operating theatre personnel evaluated by the comet assay and micronucleus test. Int J Hyg Environ Health. 2009 Jan;212(1):11-7. Epub 2007 Nov 26.</citation>
    <PMID>18023252</PMID>
  </results_reference>
  <results_reference>
    <citation>Alcaraz M, Quesada S, Armero D, Martin-Gíl R, Olivares A, Achel GD. Genotoxicity and cytotoxicity of sevoflurane in two human cell lines in vitro with ionizing radiation. Colomb Med (Cali). 2014 Sep 30;45(3):104-9. eCollection 2014 Jul-Sep.</citation>
    <PMID>25386035</PMID>
  </results_reference>
  <results_reference>
    <citation>Braz MG, Braz LG, Barbosa BS, Giacobino J, Orosz JE, Salvadori DM, Braz JR. DNA damage in patients who underwent minimally invasive surgery under inhalation or intravenous anesthesia. Mutat Res. 2011 Dec 24;726(2):251-4. doi: 10.1016/j.mrgentox.2011.09.007. Epub 2011 Sep 16.</citation>
    <PMID>21944903</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>April 5, 2017</last_update_submitted>
  <last_update_submitted_qc>April 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>genomic instability</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>General anaesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genomic Instability</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

